We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSAT icon
3801
Globalstar
GSAT
$10.2B
$77K ﹤0.01%
4,141
-1,396
-25% -$25.8K
AUR icon
3802
Aurora
AUR
$12.2B
$76.5K ﹤0.01%
+12,921
New +$53.8K
SHCR
3803
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$76.2K ﹤0.01%
53,661
-3,000
-5% -$4.16K
MTTR
3804
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$75.9K ﹤0.01%
16,876
-13,288
-44% -$57.9K
CTSO icon
3805
Cytosorbents Corp
CTSO
$23.3M
$75K ﹤0.01%
50,000
LX
3806
LexinFintech Holdings
LX
$239M
$73.4K ﹤0.01%
26,977
CNTY icon
3807
Century Casinos
CNTY
$32.6M
$72.2K ﹤0.01%
28,200
-100
-0.4% -$246
SFIX
3808
Stitch Fix
SFIX
$563M
$72K ﹤0.01%
25,531
-674
-3% -$2.62K
POET icon
3809
POET Technologies
POET
$1.17B
$68.9K ﹤0.01%
15,522
+5,422
+54% +$16.9K
ATEC icon
3810
Alphatec Holdings
ATEC
$1.43B
$68.9K ﹤0.01%
12,392
+1,039
+9% +$7.98K
GNSS icon
3811
Genasys
GNSS
$77M
$67.1K ﹤0.01%
+18,850
New +$54K
AILE
3812
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$66.8K ﹤0.01%
+40,000
New +$204K
REAL icon
3813
The RealReal
REAL
$1.44B
$66.6K ﹤0.01%
21,200
-300
-1% -$902
AVXL icon
3814
Anavex Life Sciences
AVXL
$238M
$66.1K ﹤0.01%
+11,631
New +$67.1K
STKL
3815
DELISTED
SunOpta
STKL
$65.3K ﹤0.01%
10,228
-85
-0.8% -$498
EGY icon
3816
Vaalco Energy
EGY
$540M
$64.6K ﹤0.01%
+11,255
New +$70.9K
RUM icon
3817
RUM Group Inc
RUM
$1.66B
$64K ﹤0.01%
11,938
-450
-4% -$2.65K
CRON
3818
Cronos Group
CRON
$1.06B
$62.7K ﹤0.01%
28,633
-10
-0% -$23
FFWM
3819
DELISTED
First Foundation Inc
FFWM
$62.5K ﹤0.01%
10,017
-71,412
-88% -$457K
ETON icon
3820
Eton Pharmaceutcials
ETON
$1.28B
$61.5K ﹤0.01%
10,250
PSNY icon
3821
Polestar Automotive Holding UK
PSNY
$2.03B
$60.6K ﹤0.01%
1,175
+487
+71% +$15.7K
NAT icon
3822
Nordic American Tanker
NAT
$1.35B
$60.4K ﹤0.01%
16,469
-53
-0.3% -$195
ZNTL icon
3823
Zentalis Pharmaceuticals
ZNTL
$329M
$58.4K ﹤0.01%
15,865
+4,626
+41% +$16.8K
OPK icon
3824
Opko Health
OPK
$1.25B
$57.6K ﹤0.01%
38,665
+400
+1% +$594
AVAH icon
3825
Aveanna Healthcare
AVAH
$2.15B
$57.5K ﹤0.01%
11,052

Similar funds

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.